Change spots by switching between your abdomen, thighs, and upper arms using a planned rotation
To date, no existing research has discovered any serious safety concerns with the use of GHK-Cu copper peptides
Retatrutide at doses of 4 mg or higher significantly reduced fasting insulin (by 37% to 71%), HOMA2-IR (a measure of insulin resistance, reduced by 36% to 69%), and increased adiponectin (by 30% to 99%)
If pain worsened as weight increased, this supports the metabolic-pain connection Reference the emerging research on insulin resistance in fibromyalgia, particularly the PLOS One study linking HbA1c to pain severity Propose tracking fibromyalgia-specific outcomes (Fibromyalgia Impact Questionnaire, pain diary, fatigue severity scale) alongside weight and metabolic markers If your provider manages your fibromyalgia medications, discuss the possibility of simplifying your regimen if tirzepatide produces meaningful symptom improvement Be realistic: tirzepatide isn't a fibromyalgia cure
Combining NAD+ and glutathione may support energy production, detox pathways, and metabolic health